A diagnostic challenge: Life-threatening drug reaction with eosinophilia and systemic symptoms in the setting of a SARS-CoV-2 and human herpesvirus-6 reactivation in a patient with severe hepatic injury on bupropion
Open Access
- 31 July 2023
- journal article
- Published by Elsevier in JAAD Case Reports
- Vol. 39, 101-105
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS): Focus on the Pathophysiological and Diagnostic Role of VirusesMicroorganisms, 2023
- Critical Review of Gaps in the Diagnosis and Management of Drug-Induced Liver Injury Associated with Severe Cutaneous Adverse ReactionsJournal of Clinical Medicine, 2021
- ACG Clinical Guideline: Diagnosis and Management of Idiosyncratic Drug-Induced Liver InjuryAmerican Journal of Gastroenterology, 2021
- Influence of corticosteroid therapy on viral reactivation in drug‐induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptomsThe Journal of Dermatology, 2020
- Drug-Induced liver Injury Associated with Severe Cutaneous Hypersensitivity Reactions: A Complex Entity in Need of a Multidisciplinary ApproachCurrent Pharmaceutical Design, 2019
- Acute Hepatocellular Drug-Induced Liver Injury From Bupropion and DoxycyclineACG Case Reports Journal, 2016
- Liver injury in patients with DRESS: A clinical study of 72 casesJournal of the American Academy of Dermatology, 2015
- Drug-induced autoimmune liver disease: A diagnostic dilemma of an increasingly reported diseaseWorld Journal of Hepatology, 2014
- DRESS syndromeJournal of the American Academy of Dermatology, 2013
- DRESS syndrome associated with HHV-6 reactivationEuropean Journal of Internal Medicine, 2003